
RemOmics provides bioinformatics and computational biology services to accelerate drug discovery. It combines bioinformatics, computational systems biology, and cheminformatics analytics on a unified platform, leveraging data- and AI-based medicine development. The core tech includes AI and machine learning on omics data to analyze pathways, molecular interactions, and candidate compounds. It targets biotech and pharmaceutical teams seeking streamlined analytics and candidate prioritization for research pipelines. As a B2B offering, it aims to scale research workflows across diseases and accelerate time-to-insight in life sciences R&D.

RemOmics provides bioinformatics and computational biology services to accelerate drug discovery. It combines bioinformatics, computational systems biology, and cheminformatics analytics on a unified platform, leveraging data- and AI-based medicine development. The core tech includes AI and machine learning on omics data to analyze pathways, molecular interactions, and candidate compounds. It targets biotech and pharmaceutical teams seeking streamlined analytics and candidate prioritization for research pipelines. As a B2B offering, it aims to scale research workflows across diseases and accelerate time-to-insight in life sciences R&D.